Josep M Llovet1, Richard S Finn2. 1. Mount Sinai Liver Cancer Program, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Barcelona-Clínic Liver Cancer Group (BCLC), Unitat d'Hepatologia, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. Electronic address: jmllovet@clinic.cat. 2. Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Authors: Linzi Arndt Webster; Alexander Villalobos; Bill S Majdalany; Zachary L Bercu; Ripal T Gandhi; Nima Kokabi Journal: Semin Intervent Radiol Date: 2021-10-07 Impact factor: 1.780
Authors: Josep M Llovet; Thierry De Baere; Laura Kulik; Philipp K Haber; Tim F Greten; Tim Meyer; Riccardo Lencioni Journal: Nat Rev Gastroenterol Hepatol Date: 2021-01-28 Impact factor: 46.802